<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neural cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (NCAM) is important for neuronal growth and repair </plain></SENT>
<SENT sid="1" pm="."><plain>Here we describe the development and validation of a sensitive ELISA for NCAM using commercially available reagents </plain></SENT>
<SENT sid="2" pm="."><plain>The measurable range of NCAM ELISA is 16-500 ng/mL, with a constant coefficient-of variation and good parallelism between the reference standard curve and CSF </plain></SENT>
<SENT sid="3" pm="."><plain>CSF NCAM was measured in 36 benign-intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, 51 multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, 27 neuropathy, 37 Alzheimer's disease, 12 <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, 15 motoneurone disease, 13 <z:hpo ids='HP_0001287'>meningitis</z:hpo>, 17 <z:hpo ids='HP_0002383'>encephalitis</z:hpo>, and 17 control cases </plain></SENT>
<SENT sid="4" pm="."><plain>Significant reductions were found between controls and multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and <z:hpo ids='HP_0001287'>meningitis</z:hpo> </plain></SENT>
</text></document>